ferric citrate has been researched along with Anemia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukagawa, M; Hirakata, H; Ito, K; Nakayama, M; Yokoyama, K | 1 |
| Covic, AC; Floege, J; Funk, F; Ketteler, M; Rastogi, A; Sprague, SM; Walpen, S | 1 |
| Li, W; Liao, X; Ou, J; Rao, J; Xue, C; Zhu, Y | 1 |
| Del Vecchio, L; Locatelli, F | 1 |
| Farzaneh, T; Jing, W; Khazaeli, M; Lau, WL; Nunes, ACF; Vaziri, ND | 1 |
| Asao, R; Goto, Y; Gotoh, H; Hara, M; Inagaki, M; Kenmotsu, S; Kiuchi, Y; Nakamura, M; Nakamura, Y; Nishida, K; Ohsawa, I; Suzuki, H; Tsuji, M | 1 |
| Akiba, T; Fukagawa, M; Hanaki, K; Hirakata, H; Ito, K; Nakayama, M; Wolf, M; Yokoyama, K | 1 |
| Dwyer, JP; Niecestro, R; Rodby, R; Sinsakul, M; Umanath, K | 1 |
| Blumenthal, SS; Dwyer, JP; Greco, BA; Greene, T; Hiremath, AN; Jalal, DI; Koury, MJ; Lewis, JB; Ma, KN; Manley, J; Negoi, DG; Niecestro, R; Reisin, E; Sika, M; Umanath, K; Umeukeje, EM; Zeig, S | 1 |
| Hasuike, Y; Kuragano, T; Nakanishi, T; Nanami, M; Yahiro, M | 1 |
| Locatelli, F; Mazzaferro, S; Yee, J | 1 |
| Krehbiel, JD; Lund, JE; Weiss, DJ | 1 |
5 review(s) available for ferric citrate and Anemia
| Article | Year |
|---|---|
Using iron-based phosphate binders in phosphate reduction and anemia improvement in patients receiving dialysis: a meta-analysis of randomized controlled trials.
Topics: Anemia; Carbonates; Drug Combinations; Ferric Compounds; Humans; Hyperphosphatemia; Iron; Magnesium; Randomized Controlled Trials as Topic; Renal Dialysis; Starch; Sucrose; Treatment Outcome | 2021 |
Iron-based phosphate binders: a paradigm shift in the treatment of hyperphosphatemic anemic CKD patients?
Topics: Anemia; Chelating Agents; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Renal Insufficiency, Chronic | 2017 |
Ferric citrate spans mineral metabolism and anemia domains in ESRD: a review of efficacy and safety data.
Topics: Anemia; Chelating Agents; Ferric Compounds; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Phosphates; Phosphorus | 2014 |
Novel iron-containing phosphate binders and anemia treatment in CKD: oral iron intake revisited.
Topics: Administration, Oral; Anemia; Animals; Ferric Compounds; Humans; Hyperphosphatemia; Phosphates; Renal Insufficiency, Chronic | 2016 |
Iron Therapy Challenges for the Treatment of Nondialysis CKD Patients.
Topics: Administration, Intravenous; Administration, Oral; Anemia; Ferric Compounds; Hematinics; Hemoglobins; Humans; Iron; Iron Compounds; Liposomes; Practice Guidelines as Topic; Renal Insufficiency, Chronic | 2016 |
3 trial(s) available for ferric citrate and Anemia
| Article | Year |
|---|---|
Ferric citrate hydrate is associated with a reduced cost of drugs and a smaller change in red blood cell distribution width.
Topics: Adult; Aged; Anemia; Cost-Benefit Analysis; Drug Costs; Erythrocyte Indices; Ferric Compounds; Hematinics; Humans; Middle Aged; Prospective Studies; Retrospective Studies | 2022 |
Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study.
Topics: Aged; Anemia; Female; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Hematinics; Hemoglobins; Humans; Hyperphosphatemia; Iron; Male; Middle Aged; Phosphates; Prospective Studies; Renal Dialysis | 2019 |
Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.
Topics: Administration, Intravenous; Anemia; Drug Therapy, Combination; Female; Ferric Compounds; Hematinics; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged | 2015 |
4 other study(ies) available for ferric citrate and Anemia
| Article | Year |
|---|---|
Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammation.
Topics: Administration, Oral; Anemia; Animals; Drug Combinations; Female; Ferric Compounds; Inflammation; Iron; Iron Overload; Kinetics; Male; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sucrose; Tissue Distribution | 2020 |
Phosphate Binder, Ferric Citrate, Attenuates Anemia, Renal Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in 5/6 Nephrectomized CKD Rats.
Topics: Anemia; Animals; Colon; Down-Regulation; Epithelial Cells; Ferric Compounds; Fibrosis; Inflammation; Iron; Kidney Tubules, Proximal; Male; Nephrectomy; NF-E2-Related Factor 2; Oxidative Stress; Phosphates; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Tight Junction Proteins; Up-Regulation; Zonula Occludens-1 Protein | 2018 |
Hepcidin-25/erythroferrone ratio predicts improvement of anaemia in haemodialysis patients treated with ferric citrate hydrate.
Topics: Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Hepcidins; Humans; Male; Middle Aged; Peptide Hormones; Predictive Value of Tests; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2019 |
Studies of the pathogenesis of anemia of inflammation: mechanism of impaired erythropoiesis.
Topics: Anemia; Animals; Cat Diseases; Cats; Cobalt; Erythrocyte Count; Erythropoiesis; Erythropoietin; Ferric Compounds; Hematocrit; Inflammation; Iron; Reticulocytes; Time Factors; Turpentine | 1983 |